Bläss S, Engel J M, Burmester G R
Rheumatologie und Klinische Immunologie, Charité Universitätsklinikum, Tucholskystr. 2 10117 Berlin.
Z Rheumatol. 2001 Feb;60(1):1-16. doi: 10.1007/s003930170093.
Autoreactivity plays a major role in the pathogenesis of RA. The rheumatoid factor has been and still is for now more than 50 years the only autoreactivity that is clinically applied in the diagnosis of RA. This well reflects the current way of thinking that a single antigen or a single cause drives an individual into disease. Although by now many other autoantigens and autoreactivities have been described, their discovery was always on the search for the one and only autoreactivity that causes RA. This includes also immune reactivities directed against xenogenic antigens. But, none of the known RA-associated autoreactivities is present in all RA patients and none of them occurs exclusively in RA. Thus, the observed sensitivities and specificities are well below 100%. Therefore, RA has often been postulated to consist of various immunological subentities with similar clinical symptoms. Nevertheless, none of the autoreactivities correlates with a distinct clinical feature or course of disease. It is about time to say good-bye to the idea that a single antigen or immunoreactvity causes and maintains rheumatoid arthritis. In this paper we present RA as the clinical outcome of an immune system that has shifted from a healthy to an autoimmune steady state. This is accomplished by many different reactivities and autoreactivities that occur either in parallel or one after the other. The entirety of the known RA-associated reactivities and (auto)antigens is presented in detail. The major RA-relevant autoantigens comprise BiP, citrulline, the Sa-antigen, hnRNP A2, p205, IgG, calpastatin, calreticulin, collagen and the shared HLA-DR epitope. The accumulation of factor--involving autoreactivities, cytokines, environmental and genetic factors--that challenge the normal regulatory mechanisms of the immune system lead to a regulatory catastrophe. In individuals developing the clinical features of RA the immune system has been regulated to a new--autoimmune--steady state. This attractor "rheumatoid arthritis" has many features of what has originally been described by Irun Cohen as the immunological homunculus: The healthy immune system is configured such as to direct its attention to major self-antigens. Thus it creates an autoreactivity to many autoantigens as a prerequisite for regulatory mechanisms that are sufficient to control them. The shift from the normal to rheumatoid attractor involves the inflammatory cytokines TNF-alpha, IL-1 and IL-6, autoreactive T- and B cells directed at a variety of synovial and systemic antigens, activated dendritic cells and macrophages, tissue destruction and genetic factors such as the association with shared epitope. Environmental factors involved may also, but do not necessarily, include infection. With the appearance of clinical features of RA, naive, potentially autoreactive T cells infiltrate the synovial compartment and become activated by dendritic cells and other APCs. The autoantigenic peptides that are presented to these T cells are derived from inflammatory cell and tissue destruction as well as from tissue repair and remodeling processes. These T cells proliferate and either provide help to B cells with the specificity to the same antigens or cause direct cytopathic tissue damage. Thereby, more and novel antigens are generated, released and presented again to naive or primed autoreactive T cells. These processes involving cytokines, tissue destruction and autoreactive T cells are sufficient to maintain RA even without the permanent presence of a triggering agent. The recursive autoimmune processes are well consistent with the finding of the many different autoreactivities in RA and their respective sensitivities and specificities. The massive influx of T cells into the arthritic joint is accompanied by the anergization of over 90% of T cells in this compartment--which further substantiates the concept of the RA attractor within the self-regulating immune system. Thereby, the RA-attracted immune system is not able to completely downregulate the inflammation and the local tissue damage/repair. Thus, the immune system is permanently stimulated and suddenly by chance shifts to a stable state different from the healthy system--reaching the wide fields of rheumatoid arthritis which in itself is self-sustaining as the healthy state before disease onset.
自身反应性在类风湿关节炎(RA)的发病机制中起主要作用。类风湿因子在过去50多年一直是且至今仍是临床上唯一用于RA诊断的自身反应性物质。这很好地反映了当前的一种思维方式,即单一抗原或单一病因会导致个体发病。尽管目前已经描述了许多其他自身抗原和自身反应性物质,但对它们的发现始终是在寻找导致RA的唯一自身反应性物质。这也包括针对异种抗原的免疫反应性。但是,已知的与RA相关的自身反应性物质并非在所有RA患者中都存在,也没有一种仅在RA中出现。因此,观察到的敏感性和特异性远低于100%。所以,人们常常推测RA由具有相似临床症状的各种免疫亚实体组成。然而,没有一种自身反应性与独特的临床特征或疾病进程相关。是时候摒弃单一抗原或免疫反应性导致并维持类风湿关节炎这一观念了。在本文中,我们将RA呈现为免疫系统从健康状态转变为自身免疫稳定状态的临床结果。这是通过许多不同的反应性和自身反应性物质并行或相继发生来实现的。本文详细介绍了已知的与RA相关的反应性物质和(自身)抗原。与RA相关的主要自身抗原包括结合免疫球蛋白蛋白(BiP)、瓜氨酸、Sa抗原、不均一核糖核蛋白A2(hnRNP A2)、p205、免疫球蛋白G(IgG)、钙蛋白酶抑制蛋白、钙网蛋白、胶原蛋白以及共享的人类白细胞抗原DR(HLA - DR)表位。涉及自身反应性物质、细胞因子、环境和遗传因素的积累对免疫系统的正常调节机制构成挑战,导致调节灾难。在出现RA临床特征的个体中,免疫系统已被调节到一种新的——自身免疫——稳定状态。这个吸引子“类风湿关节炎”具有伊伦·科恩最初描述的免疫小人的许多特征:健康的免疫系统被配置为将注意力导向主要自身抗原。因此,它产生对许多自身抗原的自身反应性,作为足以控制它们的调节机制的先决条件。从正常吸引子向类风湿吸引子的转变涉及炎性细胞因子肿瘤坏死因子 - α(TNF - α)、白细胞介素 - 1(IL - 1)和白细胞介素 - 6,针对多种滑膜和全身抗原的自身反应性T细胞和B细胞,活化的树突状细胞和巨噬细胞,组织破坏以及遗传因素,如与共享表位的关联。涉及的环境因素也可能(但不一定)包括感染。随着RA临床特征的出现,幼稚的、潜在的自身反应性T细胞浸润滑膜腔,并被树突状细胞和其他抗原呈递细胞(APC)激活。呈递给这些T细胞的自身抗原肽源自炎性细胞和组织破坏以及组织修复和重塑过程。这些T细胞增殖,要么为对相同抗原具有特异性的B细胞提供帮助,要么导致直接的细胞病变性组织损伤。由此,更多新的抗原被产生、释放并再次呈递给幼稚或致敏的自身反应性T细胞。这些涉及细胞因子、组织破坏和自身反应性T细胞的过程足以维持RA,即使没有触发因素的持续存在。这种递归的自身免疫过程与RA中许多不同的自身反应性及其各自的敏感性和特异性的发现高度一致。T细胞大量涌入关节炎关节伴随着该腔室中超过90%的T细胞失能——这进一步证实了自身调节免疫系统中RA吸引子的概念。由此,被RA吸引的免疫系统无法完全下调炎症和局部组织损伤/修复。因此,免疫系统被持续刺激,并偶然突然转变为不同于健康系统的稳定状态——进入类风湿关节炎的广泛领域,而类风湿关节炎本身在疾病发作前的健康状态下是自我维持的。